Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036878 · ClinicalTrials.gov registry record · NA
ReNu™ Marrow Stimulation Augmentation
A NA study, sponsored by NuTech Medical.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03036878: Clinical Trial NA study, sponsored by NuTech Medical.
NCT03036878 is a NA study that was terminated before completion, run by NuTech Medical. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03036878, a NA study, was terminated before completion, sponsored by NuTech Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To evaluate the use of ReNu™ allograft for the augmentation of marrow stimulation for osteochondral lesions
Interventions
- OTHER ReNu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2019-12-06 |
| Phase | NA |
Why NCT03036878 stopped before completion
NCT03036878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which ReNu is the first listed.
NCT03036878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03036878 about?
NCT03036878 is a clinical study titled "ReNu™ Marrow Stimulation Augmentation". To evaluate the use of ReNu™ allograft for the augmentation of marrow stimulation for osteochondral lesions
What is the current status of trial NCT03036878?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-02-07. Estimated completion is 2019-12-06.
What interventions are being tested in trial NCT03036878?
The interventions under investigation include: ReNu (OTHER).
Who is sponsoring clinical trial NCT03036878?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03036878's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI